The Cytoprotective Aminothiol WR1065 Activates p53 through a Non-genotoxic Signaling Pathway Involving c-Jun N-terminal Kinase
Open Access
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (14) , 11879-11887
- https://doi.org/10.1074/jbc.m207396200
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- c-JUN Gene Induction and AP-1 Activity Is Regulated by a JNK-Dependent Pathway in Hypoxic HepG2 CellsExperimental Cell Research, 2001
- Regulation of p53 in response to DNA damageOncogene, 1999
- Mdm2 association with p53 targets its ubiquitinationOncogene, 1998
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol®)European Journal Of Cancer, 1996
- Amifostine (WR-2721) Protects Normal Haematopoietic Stem Cells Against Cyclophosphamide Derivatives' Toxicity Without Compromising Their Antileukaemic EffectsEuropean Journal Of Cancer, 1995
- Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of actionCarcinogenesis: Integrative Cancer Research, 1995
- Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated miceEuropean Journal Of Cancer, 1994
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990